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In mice, lactic dehydrogenase virus (LDV) acts as an immunologic adjuvant 
in that it enhances the capacity of infected animals  to produce antibody to a 
foreign  protein  (human y-globulin)  (1).  However,  attempts  to demonstrate 
neutralizing  antibody  to  the virus  in  the  blood  of mice,  rabbits,  and  guinea 
pigs have been unsuccessful  (1-4). Testing for antiviral  antibody in mice was 
particularly difficult because of the lifelong viremia and  the consequent pres- 
ence  of infectious  virus  in  the  sera  of chronically infected  animals  (1).  1 The 
experiments reported herein show that (a) if measures  are  first  taken  to  inac- 
tivate  the  infectious  virus  in  the  chronic  sera,  neutralizing  antibody  can be 
demonstrated,  and  (b)  the infectious virus which persists  in the circulation of 
chronically infected mice after the appearance of anti-LDV exists in the form 
of an infectious virus-antibody complex which is relatively resistant  to further 
neutralization. 
Materials and Methods 
M/ce.---CAF-1 male and female mice were used throughout  these experiments. Mice 4 to 
6 wk old were used routinely to titer the virus. 
Antibody to Normal Mouse Sera and Normal Mouse T-GlobuUn.--Goat antl-mouse  sera 
(lot 71-227), goat anti-mouse T-globulin (lot 70898), and goat anti-human T-globulin were 
obtained from Hyland Laboratories, Los Angeles. Normal goat sera were obtained from the 
animal farm of the National  Institutes of Health and from Pentex Laboratories,  Kankakee, 
Illinois.  Rabbit anti-mouse sera was prepared by Dr. R. T. Evans of the National Institute 
of Dental Research by injecting rabbits intravenously with normal mouse sera 3 times a  week 
for 3 wk. Sera was collected 10 days after the last injection. 
* Presented in part at the 50th Annual Meeting of the American Association of Immun- 
ologists, (Fed.  Proc., Infectious virus-antibody complex, 1955, 25, 515, Abstract). 
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1 Hereinafter referred to as "chronic sera" in the interest of brevity. 
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Vir~s.--The preparation of LDV and the virus assay were performed as described previ- 
ously (5), except that each virus dilution was injected into 10 mice instead of 5. Unless indi- 
cated otherwise Eagle's basal medium with 20% veal infusion broth (EBMV) was used as the 
diluent. Acute virus pools (referred to as stock virus) were obtained from mice that had been 
infected for 24 hr. Chronic virus pools were obtained from mice that had been infected for 3 
or more months. The titer of the acute pools was  approximately 101°'° ~s0/ml, while the 
titer of the chronic pools varied between 104'0 to 105"0 ms0/mi. 
Antibody  to  Virus.--Before  the sera from LDV-infected mice could be  tested for neu- 
tralizing antibody it was necessary to render the sera noninfectious. This was done by in- 
activating the virus with ether  (6).  Serum or plasma was collected from mice at  various 
intervals after injection of the virus, pooled, and diluted with an equal volume of Eagle's basal 
medium (EBM). The diluted serum was then shaken with an equal volume of fresh ethyl 
ether (Malllnckrodt Chemical Works, St. Louis)  at room temperature for 3 rain. The aqueous 
phase was removed and shaken with ether three more times. Residual ether was removed by 
aeration with nitrogen. Serum or plasma from uninfected mice was prepared in the same way. 
Following treatment all  preparations were shown to be noninfectious and were stored until 
needed in aliquots of 0.8 ml at -55°C. The fact that a number of different pools of anti-LDV 
were prepared during the course of this work and that these pools were collected at various 
intervals after initiation of the infection might account for the differences in the degree of 
viral neutralization noted between experiments. Unless indicated otherwise, the terms anti- 
LDV and normal mouse sera refer to materials  that  had  been pretreated with ether. The 
volume of each is expressed in terms of the original undiluted sera. 
Virus NeutraUsation.--NeutraFLzation of the virus was carried out by incubating a constant 
volume of anti-LDV (0.3 ml) at 37°C for 1 hr with serial tenfold dilutions of the stock virus 
in a final volume not exceeding 1.2 ml. Reaction mixtures containing normal mouse sera were 
employed as controls in each experiment. Following incubation the reaction mixtures were 
immediately placed in ice and 0.1 ml of each mixture was injected intraperitoneally into each 
of 10 mice. The number of mice that became infected at each dilution was determined and 
the m60/ml  was calculated by the method of Reed and Muench (7). The difference in end 
points between the control and test sera was expressed in terms of a neutralization index (8). 
A difference of less than 0.7 log units was considered negative, 0.7 to less than 1.0 log units 
was equivocal, 1.0 to less than  1.5 log units as positive, and over 1.5 log units as strongly 
positive. 
In other neutralization experiments, 0.3 mi of antisera was added to a known virus concen- 
tration in a  final  volume not exceeding 1.5 ml and incubated at 37°C  for 1 hr. In each ex- 
periment virus incubated with normal mouse sera served as the control. Immediately follow- 
ing incubation the reaction mixtures were diluted serially in tenfold steps in ice cold EBMV. 
Animals were injected intraperitoneally with 0.1 ml of each of the appropriate dilutions, the 
number of animals that became infected was determined, and the virus titer was calculated. 
Virus Sensitization.--The term virus sensitization, as used throughout this paper, refers to 
the  attachment of mouse anti-LDV to  LDV without  concomitant loss of  infectivity. As 
reported below, our experiments showed that sensitization made the virus susceptible to neu- 
tralization by anti-mouse sera or anti-mouse T-globulin.  The unsensitized virus  was totally 
resistant to neutralization by these reagents. To test for sensitization, undiluted goat anti- 
mouse sera (0.2 ml) or undiluted rabbit anti-mouse sera (0.3 ml)  was incubated at 37°C for 1 
hr with a  known virus concentration in a  final volume not  exceeding  1.8 ml.  Reaction mix- 
tures containing normal goat or rabbit sera served as  controls in each experiment. Serial 
tenfold dilutions of the reaction mixtures were then prepared and 0.1 ml of each dilution was 
injected intraperitoneally into each of 10 mice. A reduction in virus titer of over 1.0 log units 
as compared to the controls was taken as positive evidence of virus sensitization. 
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at 37°C for 1 hr with serial tenfold dilutions of the virus in a final volume not exceeding 1.2 
ml. Following incubation 0.1 ml of each dilution was injected intraperitoneally  into each of 10 
mice and the neutralization index was calculated (7, 8). 
RESULTS 
Demonstration of Antibody to LDV.--Mice were infected with LDV and at 
various  times  thereafter  sera were  collected and  treated  with  ether  to  inac- 
tivate residual infectious virus. Sera from normal mice were collected and pre- 
pared in the same way. Both sera were then incubated with serial tenfold dilu- 
tions of the stock virus and the neutralization index was determined. The ex- 
TABLE I 
Time  of  Appearance of  An~LDV* 
Post-LDV  Anti-LDV~; 
wk 
o 
2 
3 
4 
10 
13 
16 
31 
o 
o 
o 
o 
4- 
+ 
++ 
++ 
* At the times indicated, sera from infected and ,,-infected mice were collected and treated 
with ether as described under Materials and Methods. Each sera was then incubated with 
serial tenfold dilutions of the stock virus and the neutralization index (NI) was determined. 
$ 0  =  negative, NI less than 0.7 log units; 4-  -- equivocal, NI 0.7 to less than 1.0 log 
units; +  =  positive, NI 1.0 to less than 1.5 log units; and ++  =  strongly positive, NI over 
1.5 log units. 
periments  summarized in Table I  failed to  reveal any neutralizing antibody 
during  the  first  month  of  the  infection.  However,  at  about  10  wk  a  small 
amount of antibody seemed to be present. At 13  wk and persisting thereafter 
neutralizing  antibody  was  readily  detected. 
To see if anti-LDV could be demonstrated as readily if the infectious virus 
in the chronic sera was inactivated by ultraviolet light (UV) rather than ether, 
the following experiment was performed. Normal mouse sera and sera from mice 
that had been infected with LDV for about 7 months were exposed to UV as 
described previously (1). Each sera was then incubated at 37°C for 1 hr with 
approximately  105"sms0/ml  of stock virus.  The  reaction mixtures  were  then 
serially diluted and  the virus titer was determined. As seen in Table II, the 
anti-LDV activity in sera prepared by the UV method was only slightly lower 
than that found in sera prepared by the ether method. Normal sera that had 
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To  demonstrate neutralizing antibody without subjecting the  sera  to  UV 
or ether treatment, the following experiment was performed. Sera from mice 
that had been infected with LDV for 3 months was diluted with an equal vol- 
ume of EBM. One-half was treated as usual with ether while the other half was 
left  untreated.  Each  preparation  was  then  incubated  with  approximately 
TABLE II 
Comparison of Anti-LDV Activity in UV and Ether-TreE,  ted Sera 
Treatment  of sera 
None 
UV 
Ether 
Virus titer mso/ml (log 10)* 
Normal sera 
5.3 
5.5 
5.3 
A~d-LDV~; 
ND§ 
3.7 
3.1 
* Approximately 106"5 ros0/ml of the stock virus was incubated with each of the sera at 
37  ° C for 1 hr. The reaction mixtures were then serially diluted and the virus titer was deter- 
mined. 
Sera from mice that had been infected with LDV for 7 months. 
§ Not done. 
TABLE III 
Anti-LD V Activity in Ether-Treated and Untreated Sara* 
Sera  Treatment  Virus tlter ms0/ml  (log 10) 
Uninfected~  None  7.7 
Infected§  None  6.6 
Infected §  Ether  6.5 
* Approximately 107'7 IDs0/ml of the stock virus was incubated with each sera  at  37°C 
for 1 hr. The reaction mixtures were then serially diluted and the virus titer was determined. 
:~ Sera from normal mice. 
§ Sera from mice that had been infected with LDV for 3 months. 
10vaID60/ml  of the stock virus at 37°C for 1 hr. Serial dilutions were performed 
and the virus titer was determined. Since sera from  the chronically infected 
mice contained approximately 10*'°IDs0/ml,  whereas  the concentration of  the 
stock virus in the reaction mixture was approximately 10VaIDs0/ml, the virus 
in the untreated chronic sera would be diluted out before the stock virus in the 
reaction mixture. This made it possible to measure the anti-LDV activity in 
the untreated sera. The data in Table III show that the untreated sera neu- 
tralized the virus to the same extent as the ether treated sera. 
Neutralization  Conditions  and  Properties  of Anti-LDV.--To  determine the 
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to contain approximately 104.rIDs0/ml and was incubated with anti-LDV under 
different time and temperature conditions. Following incubation the reaction 
mixtures were serially diluted and the virus titer was determined. As seen in 
Table IV, incubation with anti-LDV at 37°C for 1 hr decreased the virus titer 
by 1.0 log units. Incubation at 37°C for 180 rain decreased the virus titer by 
1.5 log units, but,  as indicated by the loss in virus titer in the control tube, 
the prolonged incubation had resulted in substantial  thermal inactivation of 
the virus. No detectable inactivation occurred at 37°C for 15 min or at 0°C for 
60 min. However, other experiments showed that when more potent prepara- 
TABLE IV 
E~e~t  of  Time  and  Temperature  on  Virus  NeutraUzation* 
Time 
m/n 
15 
60 
6O 
180 
Virus titer  Incubation conditions  mso/ml (log 10) 
Incubated with 
Temperature 
-c 
37 
37 
o 
37 
N'ormal Sera 
4.7 
4.5 
4.7 
3.8 
Anti-LDV~ 
4.7 
3.5 
>4.7 
2.3 
* Approximately 104"7  mso/ml of the stock virus was incubated with anti-LDV. The reac- 
tion mixtures were serially  diluted and the virus titer was determined. 
Sera from mice that had been infected with LDV for 4 months. 
tions  of  anfi-LDV  were employed,  neutralization  could  be  detected within 
15 min at 37°C and within 60 min at 0°C. 
Although anti-LDV was capable of neutralizing nearly 99 % of the stock virus 
within  1 hr  at 37°C  (Table II),  approximately 1.0%  of the virus  remained 
infectious.  To see whether the  amount of antibody in  the  reaction mixture 
was the limiting factor responsible for the residual infectious virus, the follow- 
ing  experiment  was  performed  (Table  V).  Approximately  10s'°ID60/ml  was 
incubated with normal sera (tubes A and C) or anti-LDV (tubes B and D) at 
37°C. At the end of 1 hr an additional 10~.°m60/ml was added to tubes C and 
D, while only diluent was added to tubes A and B. The reaction mixtures were 
then incubated for another hour at 37°C, serially diluted, and the virus titer 
was determined. The data in Table V show that anfi-LDV neutralized about 
99 % of the original virus (tubes A and B). When the second aliquot of virus 
was added (tubes C and D), again approximately 99% of the virus was neu- 
tralized. The results of these experiments indicate that although 1.0 %  of the 
original virus was not neutralized, anfi-LDV was in excess in the original reac- 86  IN:FECTIOUS  VI]RUS-ANTIBODY  COMPLEX 
tion mixture. The nature of this "resistant fraction" will be considered in more 
detail later in this paper. 
In the neutralization experiments described above, the amount of anti-LDV 
was always kept constant (0.3 ml) while the concentration of virus was varied 
between experiments.  To study the effect of different concentrations of anti- 
LDV on theneutralization of a constant amount of virus, anti-LDV was serially 
diluted and then incubated with 102.°m60/ml. A  1 in  10 dilution of anti-LDV 
was found to produce a substantial reduction in the neutralizing activity of the 
sera.  The possibility that low levels of an essential cofactor, such as comple- 
TABLE V 
Demonstration of Excess Antibody  in Reaction Mixture 
Incubation 
tubes* 
A 
B 
C 
D 
Incubation I 
LDV plus normal sera 
LDV plus anfi-LDV$ 
LDV plus normal sera 
LDV plus anfi-LDV$ 
Incubation II 
Diluent only 
Diluent only 
Diluent plus LDV 
Diluent plus LDV 
Virus  titer 
mB0/ml (log 10) 
4.6 
2.5 
5.4 
2.9 
* Approximately 106'° ms0/ml of the stock virus was incubated at 37°C with normal mouse 
sera or anfi-LDV (incubation I). At the end of 1 hr an additional 10  ~'° ms0/ml was added to 
tubes C and D while only diluent (EBMV) was added to tubes A and B (incubation H). 
All tubes were incubated for another hour at 37°C, serially diluted, and titered. 
:~ Sera from mice that had been infected with LDV for 5 months. 
ment, are involved in the neutralization reaction is presently under investiga- 
tion. 
Other properties  of anti-LDV were  studied  by subjecting the  antibody to 
various types of treatment and then incubating it with approximately 10  ~-5m50/ 
ml of stock virus at 37°C for 1 hr. Each reaction mixture was then injected into 
mice and the neutralizing activity of the antisera  was calculated by subtract- 
ing the percentage of mice that became infected from 100. As seen in Table VI, 
anfi-LDV that had been stored at  -55°C for 1 month or that had been dia- 
lyzed against saline for 6 hr retained its neutralizing activity. However, con- 
siderable loss of activity occurred when anti-LDV was heated at 56°C for 30 
rain. Anfi-LDV that had been pretreated at 37°C for 30 min with goat anti- 
mouse sera  or goat anti-mouse  "/-globulin  also  showed  a  substantial  loss  in 
neutralizing  activity. 
Virus  Sensitization in  Vivo.--The  presence  of  both  anfi-LDV  and  infec- 
tious virus in  the same serum pointed to the possibility that some antibody 
molecules  might be  attached  to  the  infectious virus particle  (sensitization). 
The  reaction  of  anti-mouse  sera  or  anti-mouse  y-globulin  with  anti-LDV 
(Table  VI)  suggested  that  if  anti-LDV were  attached  to  the  virus  particle A.  L.  NOTKINS,  S.  MAttAR,  C.  SCttEELE,  AND  J.  GOFFM.AN  87 
then anti-mouse  sera might also react with and possibly neutralize  the infec- 
tious  LDV-anti-LDV  complex.  To  examine  this  possibility,  virus  obtained 
from mice after  the  appearance  of circulating  anti-LDV was incubated  with 
goat anti-mouse sera or goat anti-mouse 3,-globulin.  Goat anti-human "y-glob- 
ulin and normal goat sera served as controls. Following incubation, the reaction 
mixtures were serially diluted  and  the virus titer was determined.  As seen in 
Table VII, anti-mouse sera and anti-mouse "y-globulin both reduced the virus 
titer while  anti-human 7-globulin had no effect. 
TABLE VI 
Neutralizing  Activity  of  Anti-LDV  Following Various  Types  of  Treatment 
Neutralizing  Mouse sera  Treatment  activity* 
Anti-LDV~ 
Anti-LDV 
Anfi-LDV 
Anti-LDV 
Anti-LDV 
Anti-LDV 
Normal 
Untreated 
Stored at --55°C/1 month 
Dialyzed for 6 hr§ 
Heated at 56°C/30 min 
Incubated with anti-mouse 7-globulin[] 
Incubated with anti-mouse sera[] 
Untreated 
(%) 
100 
100 
90 
40 
60 
20 
0 
* Anfi-LDV was treated in various ways and then incubated at 37°C for 1 hr with approxi- 
mately 101"5 ms0/ml of the stock virus. Each reaction mixture was then injected into mice 
and the neutralizing  activity was calculated by subtracting  the percentage of mice that be- 
came infected from 100. 
:~ Sera from mice that had been infected with LDV for 4 months. 
§ Dialyzed against saline at 4°C. 
I] Anti-LDV (0.3 ml) was incubated  at 37°C for 30 rain with goat anti-mouse sera or goat 
anti-mouse 'y-globulin (0.3 ml) prior to incubation with the virus. 
If, as the above experiment suggested, the goat anti-mouse sera was reacting 
with the anti-LDV that was attached to the virus particle, then virus obtained 
from animals before anti-LDV appeared in the circulation would not be sensi- 
tized and thus not react with the goat anti-mouse sera. To test this hypothesis, 
virus  obtained  from mice before  and  after  the  appearance  of anti-LDV was 
serially diluted  and incubated  with  goat anti-mouse sera or normal goat sera 
and  the  IDs0/ml for each  set  of dilutions  was  determined.  As seen  in  Table 
VIII, goat anti-mouse sera had no effect on the virus obtained from mice prior 
to the appearance  of anti-LDV,  whereas it produced  a  substantial  reduction 
in the titer of the virus obtained from mice after the appearance of anti-LDV. 
Similar  results  were obtained with  an anti-mouse sera prepared  in rabbits. 
To study in more detail  the time at which sensitized virus appeared in the 
circulation  of chronically infected mice,  virus pools were collected from mice 
at various intervals post-LDV. Serial tenfold dilutions of each pool were then 88  INFECTIOUS  VIRUS-ANTIBODY  COMPLEX 
incubated  with  either  goat  anti-mouse  sera  or normal  goat sera  and  the  neu- 
tralization  index  was  determined.  As  seen  in  Table  IX,  evidence  of  virus 
sensitization was not apparent until 11 wk post-LDV. Unequivocal sensitization 
TABLE VII 
Effect  of Anti-Mouse 7-Globulin  and  Anti-Mouse  Sera  on  Titer of Sensitized  Virus* 
Sera (goat) 
Normal 
Anti-human T-globulin 
Anti-mouse T-globulin 
Anti-mouse sera 
Virus titer 
mso/ml (log 10) 
2.8 
2.7 
2.0 
1.4 
* Virus obtained from mice after the appearance of circulating anti-LDV (3 months post- 
LDV)  was diluted  to contain approximately  102"s ID~0/ml and  was  incubated  at 37°C for 
1 hr with the various goat sera.  The reaction mixtures were then serially diluted and  the 
virus fiter was determined. 
TABLE VIII 
Effect of Anti-Mouse Sera on Titer of Sensitized  and  Unsensitised  Virus 
Sera 
Goat 
Normal 
Anti-mouse 
Rabbit 
Normal 
Anti-mouse 
Titer of virus 
msffml (log 10)* 
Unsensitized virus~ 
2.6 
2.6 
2.6 
2.4 
Sensitized virus§ 
2.4 
<1.0 
2.2 
<1.0 
* The virus pools were diluted to contain approximately 102.6 ms0/ml. Serial tenfold dilu- 
tions were then incubated at 37°C for 1 hr with goat or rabbit sera and the ms0/ml (log 10) 
for each set of dilutions was determined. 
:~ Obtained from mice prior to the appearance of circulating antl-LDV (2 wk post-LDV). 
§ Obtained from mice after the appearance of circulating anti-LDV (4 months post-LDV). 
was detected at  15  wk. These times correspond  closely with the appearance  of 
circulating anti-LDV  (Table I). 
If  the  goat  anti-mouse  sera  were  reacting  with  the  anti-LDV  that  was 
attached  to  the  virus  particle  then  one  would  not  expect  the  unsensitized 
progeny  of sensitized  virus  to  react  with  anti-mouse  sera.  To  see if this  were 
the  case,  sensitized  virus  was diluted  10  -~.° and 0.1  ml was injected intraperi- 
toneally into  recipient  mice.  15  hr later  the  viral progeny  was  harvested  and A. L. NOTKINS,  S. MAHAR,  C. SCHEELE, AND  J. GOFFMAN  89 
incubated  in  the  usual  way with  anti-mouse  sera.  As seen  in  Table  X,  the 
progeny failed to react with anti-mouse sera. 
Virus Sensitization in Vitro.--The following experiment was designed to see 
if unsensifized virus could be sensitized in vitro by incubation with anti-LDV. 
As outlined in Table XI, approximately 108-0iD60/ml of unsensifized stock virus 
was incubated with normal mouse sera (groups A and B) or anfi-LDV (groups 
C  and  D)  at  37°C  for  1 hr.  Immediately following incubation  the  reaction 
mixtures were diluted 10  -~.~ in ice cold EBMV. To aliquots of the latter dilu- 
tion, normal goat sera or goat anti-mouse sera was added and allowed to incu- 
bate at 37°C for 1 hr (incubation II). Each reaction mixture was then serially 
TABLE IX 
Time  of  Appearance of Seusitised  Virus 
Post-LDV*  Sensitlzed virus$ 
1 day 
2 wk 
4  cc 
9  cc 
11  " 
13  " 
15  " 
18  " 
0 
0 
0 
0 
.4_ 
-4- 
+ 
+ 
* At various times post-LDV virus pools were collected. Serial tenfold dilutions of each 
pool were then incubated with goat anti-mouse sera. Normal goat sera served as the control. 
Each set of dilutions was injected into mice and the neutralization index (NI) was determined. 
0 =  negative, NI less than 0.5 log units; q-  -- equivocal, NI 0.5 to less than 1.0 log 
units; +  =  positive, NI over 1.0 log units. 
diluted  in  ice cold EBMV and  the virus  titer  was determined.  The data  in 
Table XI show that the residual infectious virus which was not neutralized by 
mouse  anti-LDV  (group  C)  reacted  with  goat  anti-mouse  sera  (group  D), 
whereas virus incubated with normal mouse sera (group A) failed to react with 
goat anti-mouse sera (group B).  From these experiments it is concluded that 
LDV can be sensitized in vitro by incubation with anfi-LDV. 
Resistance of in  Vivo Sensitized  Virus to Neutralization by Anti-LDV.--The 
fact that infectious virus existed in the circulation of mice in the presence of 
neutralizing  antibody  suggested  that  the  sensitized  complex  was  relatively 
resistant to neutralization by anti-LDV. To see if this were the case, approxi- 
mately 103.°ms0/ml of sensitized virus which was obtained from mice that had 
been infected for 3 to 4 months was incubated at 37°C for 1 hr with anti-LDV. 
The reaction mixtures were then serially diluted and the virus titer was deter- 
mined.  As seen in Table XII, the sensitized virus was relatively resistant  to 90  INFECTIOUS  VIRUS--ANTIBODY  COMPLEX 
neutralization  by  anti-LDV.  Table  XlII  shows  that  resistant  virus  was  not 
found  in  the  circulation  until  the  14th  wk of the  infection.  This  corresponds 
TABLE X 
Effect of Anti-Mouse Sera on Progeny of Sensitized  Virus 
Type of virus*  Sera (goat)  Virus titer 
ms0/tal (log 10) 
Parent (sensitized) $ 
:Progeny§ 
Normal 
Anti-mouse 
Normal 
Anti-mouse 
3.8 
1.8 
3.1 
3.1 
* The parent virus (sensitized)  and its progeny were diluted 1 in 20 and incubated with 
goat anti-mouse sera or normal goat sera for 1 hr at 37°C. The reaction mixtures were then 
serially diluted and titered. 
:~ :parent (sensitized)  virus was obtained from mice that had been infected with LDV for 
10 months. 
§ :progeny  was  obtained  from mice 15  hr  after intraperitoneal injection of 0.1  ml of  a 
10  -a'° dilution of the parent  (sensitized)  virus. 
TABLE XI 
In Vitro Sensitizati°n of Virus* 
Group 
A 
B 
C 
D 
Incubation 1 
(mouse sera) 
Normal 
Normal 
Anti-LDV:~ 
Anti-LDV$ 
Incubation II 
(goat sera) 
Normal 
Anti-mouse 
Normal 
Anti-mouse 
* Unsensitized stock virus (approximately 10  s'° ID~0/m2 
Virus titer 
IDBo/ml (log 10) 
Experiment  No. 
1  2  3 
>4.3  4.4  4.7 
>4.3  4.4  4.4 
3.3  3.5  3.4 
2.2  2.1  2.8 
was incubated with normal mouse 
sera or mouse anti-LDV at 37°C for 1 hr  (incubation I).  Each reaction mixture was  then 
diluted  10  -a-~. To aliquots of this latter dilution, normal goat sera or goat anti-mouse sera 
was added and incubated in the usual way at 37°C for 1 hr  (incubation II). Incubation II 
was then serially diluted and the virus titer was calculated. 
Sera from mice that had been infected with LDV for 4 months. 
closely to  the  time of appearance  of anfi-LDV and  sensitized virus  (Tables  I 
and IX). 
If the resistance  of the virus  to neutralization  by anti-LDV were related  to 
sensitization,  then the unsensitized progeny should be susceptible to anti-LDV. 
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progeny should also be resistant. To differentiate between these possibilities, 
the resistant virus (sensitized) was diluted 1 in 1000 and 0.1 ml was injected 
intraperitoneaUy into recipient mice. 15 hr later the unsensitized progeny was 
TABLE XII 
Resistance of in  Vi~o Sensitized Virus* to  Neutralizalgon by Anti-LDV~ 
Reaction mixture§ 
Virus titer 
m6o/ml  (log 10) 
Experiment No. 
1  2  3 
Normal sera  3.0  2.9  2.9 
Anti-LDV  3.2  2.7  2.8 
* Sensitized virus was obtained from mice that had been infected for 3 to 4 months. 
:~ Anti-LDV was obtained from mice that had been infected for 4 months. 
§ Approximately 103"° ms0/ml of sensitized virus was incubated with anti-LDV or normal 
mouse sera at 37°C for 1 hr. The reaction mixtures were seriaDy diluted and the virus titer 
was determined. 
TABLE XIII 
Time oJ Appearance of Resistant Virus in Vivo 
Collection of virus 
(post-LDV) 
1 day 
4 wk 
ll " 
14 " 
43" 
Resistance (R) or susceptibility (S) of virus to 
neutralization as reflected by reduction in virus 
titer (log 10) following in vitro incubation with 
anti-LDV* 
1.6  (s) 
1.4  (s) 
1.3  (s) 
0,0  (R) 
0.3  (R) 
* At various times after infection virus pools were collected and diluted  1 in 100 or 1 in 
1000. Aliquots from each pool were then incubated for 1 hr at 37°C with stock anti-LDV or 
normal mouse sera. The reaction mixtures were serially diluted and the reduction in virus 
titer was calculated. A reduction in titer of less than 0.7 log units was taken as evidence of 
resistant  virus (R). 
collected  (as  in Table X)  and incubated with anti-LI)V. The data in Table 
XIV show that the unsensitized progeny was readily neutralized by anti-LDV. 
Resistance  of  in  Vitro  Sensitized  Virus  to  Neutralization  by  Anti-LDV.-- 
The above experiments showed that virus which had been sensitized in vivo 
was relatively resistant to neutralization by anfi-LDV. To see whether virus 
sensitized in vitro  also  was  resistant to  anfi-LDV the  following experiment 
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vitro (as in Table XI) by incubation with anti-LDV. Aliquots of the reaction 
mixture were then removed and tested for resistance by incubation with ex- 
TABLE XlV 
Susceptibility  of Progeny  of Resistant  Virus  to  Neutralization  by Anti-LDV* 
Incubation  Virus tlter 
Virus  (mouse serum)  n)so/ml (log 10) 
Parent (sensitized)  ~t 
Progeny (unsensitized) [] 
Normal 
Anti-LDV§ 
Normal 
Anfi-LDV§ 
2.9 
2.8 
3.6 
2.2 
* The resistant  parent (sensitized) and its progeny  (unsensitized) were diluted  1 in  20 
and 1 in 100, respectively, and then incubated with anfi-LDV at 37°C for 1 hr. The reaction 
mixtures were serially diluted and the virus titer determined. 
Parent (sensitized) virus obtained from mice that had been infected with LDV for  4 
months. 
§ Sera from mice that had been infected with LDV for about 4~ months. 
[] Progeny (unsensitized) was obtained from mice 15 hr after intraperitoneal  injection  of 
0.1 ml of a 1 in 1000-dilution of parent (sensitized) virus. 
TABLE XV 
Resistance of in Vitro Sensitized  Virus to Further Neutralization  by Anti-LDV* 
Group  Incubation I~ 
Normal Sera 
Anti-LDV§ 
Anti-LDV§ 
Incubation II$ 
Normal Sera 
Normal Sera 
Anti-LDV§ 
Virus titer 
m6o/ml(log 10) 
Experiment No. 
1  2 
4.8  >4.2 
3.0  3.0 
3.1  2.9 
* Unsensitized stock virus (approximately 10  s'° m60/ml) was incubated in the usual  way 
with 0.3 ml of anti-LDV or normal mouse sere in a final volume of 1.2 ml (incubation I). 
Aliquots of 0.3 ml were then removed and incubated with an additional 0.3 ml of anti-LDV 
or normal mouse sera in a final volume of 1.5 ml (incubation II). Incubation II was then 
serially diluted and the virus fiter calculated. 
:~ Incubated at 37°C for 1 hr. 
§ Sera from mice that had been infected with LDV for 5 months. 
cess anti-LDV. As seen in Table XV,  the in vitro sensitized virus (groups B 
and C)  was resistant to further neutralization. However, it should be empha- 
sized that the degree of resistance does vary with the amount of antibody used 
to sensitize the virus, the amount of antibody employed in the neutralization 
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DISCUSSION 
Because of the lifelong viremia, it was thought previously that mice made 
little if any neutralizing antibody to LDV (1-4). However, attempts to test 
for neutralizing antibody were always hampered by the presence of infectious 
virus  in  the  chronic sera.  The  experiments  reported  herein  showed  that  if 
measures were first taken to inactivate or dilute out the infectious virus in the 
chronic sera, neutralizing antibody could be demonstrated. These findings sug- 
gest  that  the  detection  of neutralizing  antibody  in  other  chronic viremias, 
such as the viral leukemias in mice, might be greatly facilitated if the infectious 
virus in the test sera is first inactivated or removed. 
Although neutralizing antibody appeared at about 21/~ months after initia- 
tion of the infection, the LDV-viremia persisted. The persistence of infectious 
virus in serum containing antibody suggested  that some antibody molecules 
might be attached to the residual infectious particles (sensitized virus). The 
demonstration that goat anti-mouse sera or goat anti-mouse ~,-globulin could 
inactivate mouse anti-LDV,  pointed to  the  possibility  that  anti-mouse  sera 
might also react with the LDV-anti-LDV complex. That this was the case was 
illustrated by the fact that infectious virus which persisted after in vivo or in 
vitro exposure to mouse anti-LDV was readily neutralized by anti-mouse sera 
or  anti-mouse  ~,-globulin,  whereas  virus  not  previously  exposed  to  mouse 
anti-LDV (unsensitized virus) was totally resistant to neutralization by anti- 
mouse sera. Thus, by the use of an anti-mouse sera we were able to show that 
mouse anti-LI)V was  actually attached to the virus particle and that sensi- 
tization did not result in loss of infectivity. From these findings it is suggested 
that  the  use  of  an  anti-~-globulin  in  other  virus-antibody  systems  might 
(a) prove to be a useful method for detecting sensitized virus, (b) aid in demon- 
strating otherwise undetectable antiviral antibody, and  (c)  be useful in neu- 
tralizing the so-called "resistant fraction". Support for these suggestions comes 
from recent experiments in which we sensitized herpes simplex virus with an 
antiherpes  serum made in  rabbits  and  found that  we could neutralize over 
99.9% of the infectious herpes-antiherpes complex with an anti-rabbit serum 
made in goats (10). 
The  experiments  described  above  showed  that  sensitized  virus  could  be 
neutralized by antibody which was not directed against the virus particle itself. 
The mechanism  of neutralization of sensitized virus  requires further study, 
but we should like to enumerate what we consider the most likely possibilities. 
First,  anti-mouse  sera  or  anti-mouse T-globulin might  act  by attaching  to 
and/or forming a bridge between anti-LDV molecules which are bound to the 
surface of the sensitized particle so as to block critical sites (areas which must 
not be altered or blocked if the virus is to remain infective). Second, anti-mouse 
sera might form a lattice between sensitized particles. However, the neutraliza- 
tion of extremely low concentrations of sensitized virus (less than 100 m~0/ml) 
by anti-mouse sera is difficult to explain on the basis of lattice formation. Third, 94  INFECTIOUS  VIRUS-ANTIBODY  COMPLEX 
anti-mouse  sera or anti-mouse "g-globulin  might  interact with  the  anti-LDV 
which is attached to the virus particle in such a  way as to pull the anti-LDV 
off the virus and in so doing disrupt  or damage  the  infectious particle with 
resulting loss of infectivity. Further  studies  are  required  to  differentiate be- 
tween these possibilities. 
The persistence of a  relatively resistant  virus  fraction following in  vitro 
incubation with antiviral antibody is not unique for LDV. Similar findings have 
been reported with a number of other viruses including polio, western equine 
encephalitis, Newcastle disease, influenza, rabbitpox,  Japanese B  encephalitis, 
foot-and-mouth disease, visna, and herpes simplex (11-25). The present study 
with LDV, however, showed that in addition to a resistant fraction in vitro, a 
similar fraction exists in vivo soon after the appearance of circulating antibody. 
In addition, our studies showed that the resistant fraction, in contrast to the 
susceptible fraction, was sensitized with anti-LDV. These observations suggest 
that  sensitization  of the  virus might  hinder neutralization and produce the 
so-called resistant fraction. A somewhat similar hypothesis has been proposed 
to account for the resistant fraction in other virus-antibody systems  (13-19, 
21, 22, 25-27). Recent studies on the interaction of virus and antibody which 
employed density  gradient  centrifugation,  electrophoretic mobility,  and  an 
aqueous polymer phase system provide tentative support for this hypothesis 
(18,  25-27).  These experiments showed  that  the infectious virus which  per- 
sisted after exposure to antiviral antibody migrated with or was found in asso- 
ciation with the globulin fractions. Our demonstration that an anti-3,-globulin 
could in fact neutralize the resistant virus showed that the antiviral antibody 
was actually attached to the infectious particle. Although these findings pointed 
to viral sensitization as the most likely explanation for resistance, the existence 
of a  genetic or phenotypic variant which was insusceptible to neutralization 
but not to sensitization had to be ruled out. The susceptibility of the progeny 
of  the  resistant  virus  to  neutralization  by  anti-LDV  (Table  XIV)  argues 
against a genetic variant. A phenotypic variant seems unlikely on the basis of 
preliminary experiments (discussed below) which indicate  that the  degree  of 
resistance is a  function of the neutralization conditions. Furthermore, to ex- 
plain the resistance of LDV or that of other viruses in terms of a phenotypic 
variant would require additional and more complicated assumptions than are 
warranted on the basis of available evidence. 
Finally, we should like to consider the relationship between viral neutral- 
ization, sensitization, and resistance. If one postulates that on each virus par- 
ticle there are critical and noncritical sites,  then attachment of antibody to 
critical sites would result in viral neutralization. On  the other hand,  attach- 
ment of antibody to noncritical sites would result in sensitization. If some of the 
noncritical sites are in close proximity to the critical sites, attachment of anti- 
body to these noncritical sites might sterically hinder free antibody molecules 
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tively resistant  to neutralization.  The degree of resistance  to neutralization 
would depend on the extent of the sensitization and the sites involved. Evi- 
dence for this latter contention comes from recent studies  (9), which showed 
that a dilution of anti-LDV which was insufficient to neutralize LDV was ade- 
quate to sensitize the virus. However, the degree of sensitization in this case 
was  inadequate  to  protect the virus from neutralization by undiluted  anti- 
LDV. On the other hand, as shown in this paper, a concentration of anti-LDV 
which neutralized close to 99 %  of the virus, left a  residual sensitized fraction 
which was relatively resistant to further neutralization. Whether the sensitiza- 
tion and neutralization of LDV are produced by the same or different types of 
antibody is not known. Lafferty (18, 27) recently found that papaln-digested 
monovalent  antibody  protected  influenza virus  from  neutralization  by  un- 
digested divalent antibody. Similarly, if there are two types of anti-LDV, the 
attachment  of "sensitizing"  or  "nonavid"  antibody  (28)  to  critical  and/or 
noncritical sites might protect the virus from neutralizing antibody and pro- 
duce a  resistant fraction. Although it is not possible at  the present time to 
differentiate between these alternatives, we believe that further studies on the 
mechanism and kinetics of virus sensitization may aid in elucidating the factors 
which affect the susceptibility and resistance of a virus to neutralization. 
SUMMARY 
If viremic sera  from mice  chronically infected with  lactic dehydrogenase 
virus (LDV) were first treated with ether or ultraviolet light to inactivate the 
infectious  virus,  neutralizing  antibody  could  be  demonstrated.  Significant 
amounts of antibody, however, were not detected until the mice had been in- 
fected for about 2~ months and its presence did not result in the elimination 
of the chronic viremia. Virus isolated from sera containing neutralizing anti- 
body  was  found  to  be  relatively  resistant  to  neutralization  by  anti-LDV. 
Further studies revealed that the resistant virus existed in the form of an in- 
fectious virus-antibody complex (sensitized virus). The presence of such a com- 
plex was demonstrated by the fact that the virus fraction which persisted after 
in vivo or in vitro exposure to mouse anti-LDV was readily neutralized by goat 
anti-mouse  sera  or goat  anti-mouse v-globulin,  whereas virus  that  had  not 
been previously exposed to mouse anti-LDV was completely resistant to neu- 
tralization by goat anti-mouse sera. These findings suggest that (a) sensitiza- 
tion may play an important role in the resistance and susceptibility of a virus 
to neutralization by antiviral antibody, and (b) an anti-'y-globulin may prove 
useful  in neutralizing  the  resistant  fraction and  in demonstrating  otherwise 
undetectable antiviral antibody. 
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